Supplementary Figure 1 from Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131)

Key Points

• Cell-free DNA yield was measured in ng per ml plasma, highlighting significant variations across diagnostic groups.
• Patients showed differing levels of cell-free DNA yield, with specific findings relevant to tumor tissue genotyping.
• Assessment involved categorizing plasma DNA yield according to diagnostic classifications, contributing to better understanding of DNA analysis.
• Findings suggest that plasma DNA genotyping could complement tumor tissue testing for improved diagnostic accuracy.

Abstract